Oregon Hodgkins Survivor Featured in Surfing Magazine

Pamela Clark, a two time Hodgkin's Lymphoma survivor, is a Portland resident. She has been surfing for three years, and will be featured in the Spring 2005 issue of Surf Life for Women magazine. In this article, the story of Pamela's bone marrow transplant and her continued surfing during and after the transplant is discussed.



Pamela was first diagnosed in August 2002, and her second reoccurrence was diagnosed in December 2003. Pamela had an autologous stem cell bone marrow transplant done at the Seattle Cancer Care Alliance, under protocols developed by the Fred Hutchinson Cancer Research Center.



33 year old Pamela has lived in the Portland area with her husband and pound puppy for the past eight years. She surfs the Oregon coast year round, going out several times a week. She is helping to organize the 4th Annual Clean Water Classic surfing contest, which is a benefit event for the Surfrider Foundation. The Classic will take place on May 14-15th in Westport, WA. Pamela will also be participating in the 2005 Leukemia & Lymphoma Society's Man/Woman of the Year contest, in which 10 Oregonians engage in a friendly competition for a two month period to see who can raise the most money for the Leukemia & Lymphoma Society. This contest starts on April 28th and concludes on June 23rd, 2005. More information on Pamela can be found at http://www.pamelaclark.info/ (after March 5th).

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap